Are you Dr. Pollock?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3811 Ohara St
Pittsburgh, PA 15213Phone+1 412-624-1000
Summary
- Dr. Bruce Pollock, MD is a psychiatrist in Pittsburgh, Pennsylvania.
Education & Training
University of Toronto Faculty of MedicineClass of 1979
Clinical Trials
- Serotonergic Pharmacotherapy for Agitation of Dementia Start of enrollment: 1995 Sep 01
- Treating Behavioral Disturbances in Individuals With Dementia Start of enrollment: 2000 Jan 01
- Antidepressant Medication Plus Donepezil for Treating Late-life Depression Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 92 citationsIndividual determinants of COVID-19 vaccine hesitancy.Philip Gerretsen, Julia Kim, Fernando Caravaggio, Lena C. Quilty, Marcos Sanches
Plos One. 2021-11-17 - A measure of illness awareness in individuals with nicotine dependence - Nicotine Use Awareness and Insight Scale (NAS).Julia Kim, Yasaman Kambari, Anmol Taggar, Lena C. Quilty, Peter Selby
Nicotine & Tobacco Research. 2021-11-12 - A calcium fluorescence assay for quantification of cholinergic receptor activity of clinical drugs in serum - comparison with radioactive methods.José N. Nobrega, Roger Raymond, Tarek K. Rajji, Bruce G. Pollock
Journal of Pharmacological and Toxicological Methods. 2021-11-01
Press Mentions
Annual Meeting 2021 Preliminary Program GuideMarch 1st, 2021
Dementia Study SHOCK - Experts Warn Link to Alcohol Could Be WORSE Than ThoughtFebruary 27th, 2018
Alcohol Consumption Biggest Risk Factor for Dementia: StudyFebruary 23rd, 2018- Join now to see all
Grant Support
- Maintenance Therapies In Late-Life Depression-IiiNational Institute Of Mental Health2005–2008
- Geropsychopharmacology: Enhancing Benefit, Reducing RiskNational Institute Of Mental Health2002–2006
- Continuation Pharmacotherapy For Agitation Of DementiaNational Center For Research Resources2004–2005
- Atypical Antipsychotics: Determinants Of ConcentrationNational Institute Of Mental Health2001–2004
- Continuation Pharmacotherapy For Agitation Of DementiaNational Institute Of Mental Health2000–2004
- Core--Geriatric PsychopharmacologyNational Institute Of Mental Health2000–2002
- Serotonergic Pharmacotherapy For Agitation Of DementiaNational Center For Research Resources2000–2002
- Geropsychopharmacology--Enhancing Benefit, Reducing RiskNational Institute Of Mental Health1997–2001
- Core--Geriatric Clinical PsychopharmacologyNational Institute Of Mental Health1996–1999
- Serotonergic Pharmacotherapy For Agitation Of DementiaNational Institute Of Mental Health1995–1999
- Geriatric Neuroleptic Metabolism And ToxicityNational Institute Of Mental Health1992–1996
